Skip to content
healthcare.dev

RYNEX PSE

NDC 0485-0206, BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE, liquid, from EDWARDS PHARMACEUTICALS, INC..

Product NDC
0485-0206
Status
Listed
Labeler
EDWARDS PHARMACEUTICALS, INC.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0206 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BROMPHENIRAMINE MALEATE1 mg/5mL
  • PSEUDOEPHEDRINE HYDROCHLORIDE15 mg/5mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0485-0206-1600485020616473 mL in 1 BOTTLE, PLASTIC (0485-0206-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0485-0206 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0206 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0485-0206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.